Brainstorm Cell Therapeutics, Inc. (BCLI)

1.05 -0.02 (-1.87%) USD  |  OTCM  |  Sep 04, 16:00
More

Brainstorm Cell Therapeutics SG&A Expense (TTM) : 6.474M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 6.474M
March 31, 2026 5.277M
December 31, 2025 5.778M
September 30, 2025 5.852M
June 30, 2025 6.707M
March 31, 2025 7.314M
December 31, 2024 7.042M
September 30, 2024 8.682M
June 30, 2024 9.384M
March 31, 2024 9.979M
December 31, 2023 10.69M
September 30, 2023 10.05M
June 30, 2023 10.41M
March 31, 2023 10.23M
December 31, 2022 10.87M
September 30, 2022 10.94M
June 30, 2022 9.531M
March 31, 2022 9.575M
December 31, 2021 9.304M
September 30, 2021 9.44M
June 30, 2021 10.40M
March 31, 2021 9.583M
December 31, 2020 9.355M
September 30, 2020 8.163M
June 30, 2020 7.088M
Date Value
March 31, 2020 6.685M
December 31, 2019 5.797M
September 30, 2019 5.895M
June 30, 2019 5.609M
March 31, 2019 5.912M
December 31, 2018 5.77M
September 30, 2018 5.522M
June 30, 2018 5.489M
March 31, 2018 4.523M
December 31, 2017 4.022M
September 30, 2017 3.02M
June 30, 2017 2.644M
March 31, 2017 2.836M
December 31, 2016 2.833M
September 30, 2016 3.077M
June 30, 2016 3.297M
March 31, 2016 3.453M
December 31, 2015 3.587M
September 30, 2015 4.039M
June 30, 2015 3.827M
March 31, 2015 3.256M
December 31, 2014 2.647M
September 30, 2014 2.151M
June 30, 2014 1.567M
March 31, 2014 1.893M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
NovelStem International Corp. 0.1201M
Summit Therapeutics, Inc. 306.10M
Kezar Life Sciences, Inc. 18.27M
Protara Therapeutics, Inc. 23.56M
Clene, Inc. 7.873M